Suppr超能文献

相似文献

1
Aldo-keto reductase (AKR) superfamily website and database: An update.
Chem Biol Interact. 2024 Aug 1;398:111111. doi: 10.1016/j.cbi.2024.111111. Epub 2024 Jun 13.
2
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Aldo-keto reductase (AKR) superfamily: genomics and annotation.
Hum Genomics. 2009 Jul;3(4):362-70. doi: 10.1186/1479-7364-3-4-362.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Home treatment for mental health problems: a systematic review.
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.

引用本文的文献

1
Brief Warm and Aldo-Keto Reductase Family Contribute to Cold Adaptation of .
Insects. 2025 Jan 2;16(1):38. doi: 10.3390/insects16010038.
2
Specific and potent inhibition of steroid hormone pre-receptor regulator AKR1C2 by perfluorooctanoic acid: Implications for androgen metabolism.
J Steroid Biochem Mol Biol. 2025 Feb;246:106641. doi: 10.1016/j.jsbmb.2024.106641. Epub 2024 Nov 20.

本文引用的文献

1
Aldo-keto reductase-7A2 protects against atorvastatin-induced hepatotoxicity via Nrf2 activation.
Chem Biol Interact. 2024 Apr 25;393:110956. doi: 10.1016/j.cbi.2024.110956. Epub 2024 Mar 12.
2
A three-level regulatory mechanism of the aldo-keto reductase subfamily AKR12D.
Nat Commun. 2024 Mar 8;15(1):2128. doi: 10.1038/s41467-024-46363-z.
3
Multiomics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney Disease.
Diabetes. 2024 Jul 1;73(7):1188-1195. doi: 10.2337/db23-0540.
4
Aldo-keto reductase 1B10 as a Carcinogenic but Not a Prognostic Factor in Colorectal Cancer.
J Cancer. 2024 Jan 27;15(6):1657-1667. doi: 10.7150/jca.91064. eCollection 2024.
6
A Composite Blood Biomarker Including AKR1B10 and Cytokeratin 18 for Progressive Types of Nonalcoholic Fatty Liver Disease.
Diabetes Metab J. 2024 Jul;48(4):740-751. doi: 10.4093/dmj.2023.0189. Epub 2024 Feb 1.
8
Aldo-keto reductases 7A subfamily: A mini review.
Chem Biol Interact. 2024 Mar 1;391:110896. doi: 10.1016/j.cbi.2024.110896. Epub 2024 Jan 30.
9
Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma.
J Hepatocell Carcinoma. 2024 Jan 16;11:131-143. doi: 10.2147/JHC.S443006. eCollection 2024.
10
Aldo-keto reductase family member C3 (AKR1C3) promotes hepatocellular carcinoma cell growth by producing prostaglandin F2α.
Oncol Res. 2023 Nov 15;32(1):163-174. doi: 10.32604/or.2023.030975. eCollection 2023.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验